TrialCancer research and treatment2017

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer.

Youngjoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.